STZ transport and cytotoxicity: Specific enhancement in GLUT2-expressing cells

Diabetes

Volumn 43, Issue 11, 1994, Pages 1326-1333

  Schnedl, Wolfgang J ^a   Ferber, Sarah ^a   Johnson, John H ^a,b   Newgard, Christopher B ^a,c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE DERIVATIVE; GLUCOSE TRANSPORTER; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL LINE; CONTROLLED STUDY; CYTOTOXICITY; DIABETOGENESIS; DRUG EFFECT; DRUG TRANSPORT; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HISTOLOGY; IMPLANTATION; INSULIN BLOOD LEVEL; INSULINOMA; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; NUDE MOUSE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; TUMOR CELL LINE;

EID: 0028604486     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.43.11.1326     Document Type: Article

References (27)

1. Weiss RB: Streptozocin: a review of its pharmacology, efficacy, and toxicity. Cancer Treat Rep 66:427-438, 1982
2. Okamoto H: Molecular basis of experimental diabetes: degeneration, oncogenesis and regeneration of pancreatic β-cells of islets of Langerhans. Bioessays 2:15-21, 1985
3. Sener A, Malaisse-Lagae F, Giroix M-H, Malaisse WJ: Sensitivity to pentamidine but resistance to streptozotocin of tumoral insulin-producing cells (RINm5F line). Pancreas 1:550-555, 1986
4. Hughes SD, Johnson JH, Quaade C, Newgard CB: Engineering of glucose-stimulated insulin secretion and biosynthesis in non-islet cells. Proc Natl Acad Sci USA 89:688-692, 1992
5. Hughes SD, Quaade C, Johnson JH, Ferber S, Newgard CB: Transfection of AtT-20ins cells with GLUT-2 but not GLUT-1 confers glucose-stimulated insulin secretion: relationship to glucose metabolism. J Biol Chem 268:15205-15212, 1993
6. Ferber S, BeltrandelRio H, Johnson JH, Noel RJ, Cassidy L E, Clark S, Becker TC, Hughes SD, Newgard CB: GLUT-2 gene transfer into insulinoma cells confers both low and high affinity glucose-stimulated insulin release: relationship to glucokinase activity. J Biol Chem 269:11523-11529, 1994
7. Clark SA, Burnham BL, Chick WL: Modulation of glucose-induced insulin secretion from a rat clonal β-cell line. Endocrinology 127:2779-2788, 1990
8. Moore H-P, Walker MD, Lee F, Kelly RB: Expressing a human proinsulin cDNA in a mouse ACTH-secreting cell: intracellular storage, proteolytic processing, and secretion on stimulation. Cell 35:531-538, 1983
9. Ogawa A, Johnson JH, Ohneda M, McAllister CT, Inman L, Alam T, Unger RH: Roles of insulin resistance and β-cell dysfunction in dexamethasone-induced diabetes. J Clin Invest 90:497-504, 1992
10. Weibel ER: Practical methods for biological morphometry. In Stereological Methods. London, Academic, 1979, p. 101-161
11. Janjic D, Wollheim CB: Islet cell metabolism is reflected by the MTT (tetrazolium) colorimetric assay. Diabetologia 35:482-485, 1992
12. Forist AA: Spectrophotometric determination of streptozotocin. Anal Chem 36:1338-1339, 1964
13. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254, 1976
14. Johnson JH, Newgard CB, Milburn JL, Lodish HF, Thorens B: The high Km glucose transporter of islets of Langerhans is functionally similar to the low affinity transporter of liver and has an identical primary sequence. J Biol Chem 265:6548-6551, 1990
15. Hughes SD, Quaade C, Milburn JL, Cassidy LC, Newgard CB: Expression of normal and novel glucokinase mRNAs in anterior pituitary and islet cells. J Biol Chem 266:4521-4530, 1991
16. Newgard CB: Cellular engineering for the treatment of metabolic disorders: prospects for therapy in diabetes. Biotechnology 1112-1120, 1992
17. Miyaura C, Chen L, Appel M, Alam T, Hughes SD, Milbum JL, Unger RH, Newgard CB: Expression of reg/PSP, a pancreatic exocrine gene: relationship to changes in islet β-cell mass. Mol Endocrinol 5:226-234, 1991
18. Chen L, Alam T, Johnson JH, Hughes SD, Newgard CB, Unger RH: Regulation of β-cell glucose transporter gene expression. Proc Natl Acad Sci USA 87:4088-4092, 1990
19. Tuch BE, Turtle JR, Simeonovic CJ: Streptozotocin is not toxic to the human fetal B-cell. Diabetologia 32:678-684, 1989
20. LeDoux SP, Wilson GL: Effects of Streptozotocin on a clonal isolate of rat insulinoma cells. Biochim Biophys Acta 804:387-392, 1984
21. Wilson GL, Hartig PC, Patton NJ, LeDoux SP: Mechanisms of nitrosourea-induced β-cell damage: activation of poly (ADP-ribose) synthetase and cellular distribution. Diabetes 37:213-216, 1988
22. Thorens B, Sarkar HK, Kaback HR, Lodish HF: Cloning and functional expression in bacteria of a novel glucose transporter present in liver, intestine, kidney and β-pancreatic islet cells. Cell 55:281-290, 1988
23. Like AA, Rossini AA: Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 193:415-417, 1976
24. Yamada K, Nonaka K, Hanafusa T, Miyazaki A, Toyoshima H, Tarui S: Preventive and therapeutic effects of large-dose nicotinamide injections on diabetes associated with insulitis: an observation in nonobese diabetic (NOD) mice. Diabetes 31:749-753, 1982
25. Karam JH, Lewitt PA, Young CW, Nowlain RE, Frankel BJ, Fujiya H, Freedman ZR, Grodsky GM: Insulinopenic diabetes after rodenticide (Vacor) ingestion: a unique model of acquired diabetes in man. Diabetes 29:971-978, 1980
26. Helgason T, Ewen SWB, Ross IS, Stowers JM: Diabetes produced in mice by smoked/cured mutton. Lancet 2:1017-1022, 1982
27. Nathan CF: Secretory products of macrophages. J Clin Invest 79:319-326, 1987